Anagin Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Anagin Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11020
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Anagin Inc (Anagin) formerly Anagin LLC, is a biotechnology company which develops novel targeted therapies for the treatment of neuropsychiatric diseases. The company is focused on the development of first-in-class small molecule modulators of neurotransmitter signaling complexes that reduce excessive nitric oxide production in specific regions of the brain in the presence of fear or injury while eliminating unwanted side effects such as learning and memory deficits, hallucinations and ataxia. Anagin uses Indiana University technology to develop treatment for psychiatric diseases including Post Traumatic Stress Disorder (PTSD), Traumatic Brain Injury (TBI), depression, neuropathic pain, Alzheimer’s disease and Parkinson’s disease. Anagin is headquartered in Indianapolis, Indiana, the US.

Anagin Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Anagin Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anagin Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Anagin Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anagin Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Anagin Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Anagin Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Anagin Raises USD1.3 Million in Venture Financing 10
Anagin Raises Additional USD2.1 Million in Venture Financing 11
Anagin Raises USD1 Million in Venture Financing 12
Anagin Inc – Key Competitors 13
Anagin Inc – Key Employees 14
Anagin Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Anagin Inc, Pharmaceuticals & Healthcare, Key Facts 2
Anagin Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anagin Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Anagin Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anagin Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Anagin Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Anagin Raises USD1.3 Million in Venture Financing 10
Anagin Raises Additional USD2.1 Million in Venture Financing 11
Anagin Raises USD1 Million in Venture Financing 12
Anagin Inc, Key Competitors 13
Anagin Inc, Key Employees 14

List of Figures
Anagin Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Anagin Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Anagin Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Anagin Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Anagin Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anagin Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Anagin Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anagin Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Anagin Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • REVA Medical Inc (RVA):企業の財務・戦略的SWOT分析
    Summary REVA Medical Inc (REVA) is a medical device company that offers bioresorbable polymer technologies for vascular applications. The company offers solutions for patient health restoration through the application of biomaterials in the development and sale of implantable medical devices. It off …
  • Banque Cantonale de Geneve Private Banking:企業の戦略・SWOT・財務情報
    Banque Cantonale de Geneve Private Banking - Strategy, SWOT and Corporate Finance Report Summary Banque Cantonale de Geneve Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Specialist Investment Properties PLC:企業の戦略・SWOT・財務分析
    Specialist Investment Properties PLC - Strategy, SWOT and Corporate Finance Report Summary Specialist Investment Properties PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Avanos Medical Inc (HYH):医療機器:M&Aディール及び事業提携情報
    Summary Avanos Medical Inc (Avanos Medical), formerly Halyard Health Inc is a medical technology company that provides medical devices and equipments. The company offers clinically-superior products and solutions in digestive health, pain management, infection prevention, surgical solutions and IV t …
  • HollyFrontier Corporation (HFC)-石油・ガス分野:企業M&A・提携分析
    Summary HollyFrontier Corporation (HollyFrontier) is an independent energy company. It carries out crude oil refining and wholesale marketing of refined petroleum products. The company produces and markets high-value light products such as gasoline, diesel, jet fuel, specialty lubricant products, he …
  • Eolus Vind AB (EOLU B):企業の財務・戦略的SWOT分析
    Summary Eolus Vind AB (Eolus Vind) is a wind farm developer that offers construction, development, and operation of green field projects and wind power plants. The company offers services such as consultancy services, administration, financing, development, and management of wind farms. It also offe …
  • Kronos Worldwide Inc (KRO):企業の財務・戦略的SWOT分析
    Kronos Worldwide Inc (KRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Maastricht University:医療機器:M&Aディール及び事業提携情報
    Summary Maastricht University (MU) is an educational service provider that offers academic programs such as bachelor degree, master and doctoral programs. The university offers postgraduate research degrees in various subjects for a range of research needs and interests. It offers programs through i …
  • Tokyo Broadcasting System Holdings, Inc. (9401):企業の財務・戦略的SWOT分析
    Tokyo Broadcasting System Holdings, Inc. (9401) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Micron Technology Inc:企業の戦略・SWOT・財務情報
    Micron Technology Inc - Strategy, SWOT and Corporate Finance Report Summary Micron Technology Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Women’s Choice Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Women's Choice Pharmaceuticals LLC (WCP) is a pharmaceutical company that offers prescription products for women’s health care and urology markets. The company’s products include fem pH, a therapeutic vaginal jelly that is used to promote and maintain vaginal acidity caused by diabetes, horm …
  • Port of Rotterdam Authority NV:企業の戦略的SWOT分析
    Port of Rotterdam Authority NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Eaton Vance Corp:企業の戦略・SWOT・財務分析
    Eaton Vance Corp - Strategy, SWOT and Corporate Finance Report Summary Eaton Vance Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • China Telecom Corporation Limited:戦略・SWOT・企業財務分析
    China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Aerosonic, LLC:企業の戦略・SWOT・財務情報
    Aerosonic, LLC - Strategy, SWOT and Corporate Finance Report Summary Aerosonic, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cardiovascular Systems Inc (CSII):製品パイプライン分析
    Summary Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for treating peripheral and coronary vascular disease. The company offers products such as peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accessorie …
  • Sanofi (SAN):企業の財務・戦略的SWOT分析
    Sanofi (SAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • IO Biotech ApS:製薬・医療:M&Aディール及び事業提携情報
    Summary IO Biotech ApS (IO Biotech) is a clinical stage biotechnology company, which develops disruptive immune modulating anti-cancer medicines. The company developed a pipeline of first-in-class anti-cancer drugs harnessing a unique technology platform, T-Win. IO Biotech's immuno-oncology therapie …
  • Trivitron Healthcare Pvt Ltd:企業のM&A・事業提携・投資動向
    Trivitron Healthcare Pvt Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Trivitron Healthcare Pvt Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Casual Dining Group Ltd.:企業の戦略・SWOT・財務情報
    Casual Dining Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Casual Dining Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆